BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26771086)

  • 1. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.
    Jiang Z; Luo HY; Huang S; Farrell JJ; Davis L; Théberge R; Benson KA; Riolueang S; Viprakasit V; Al-Allawi NA; Ünal S; Gümrük F; Akar N; Başak AN; Osorio L; Badens C; Pissard S; Joly P; Campbell AD; Gallagher PG; Steinberg MH; Forget BG; Chui DH
    Br J Haematol; 2016 Mar; 172(6):958-65. PubMed ID: 26771086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.
    So CC; Song YQ; Tsang ST; Tang LF; Chan AY; Ma ES; Chan LC
    J Med Genet; 2008 Nov; 45(11):745-51. PubMed ID: 18697826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
    Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
    J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
    Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering the genetics underlying foetal haemoglobin production in adults.
    Thein SL; Menzel S
    Br J Haematol; 2009 May; 145(4):455-67. PubMed ID: 19344402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
    Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
    Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
    Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
    Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of HbF Enhancer Haplotypes at
    Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
    Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
    [No Abstract]   [Full Text] [Related]  

  • 15. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.
    Farrell JJ; Sherva RM; Chen ZY; Luo HY; Chu BF; Ha SY; Li CK; Lee AC; Li RC; Li CK; Yuen HL; So JC; Ma ES; Chan LC; Chan V; Sebastiani P; Farrer LA; Baldwin CT; Steinberg MH; Chui DH
    Blood; 2011 May; 117(18):4935-45. PubMed ID: 21385855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
    Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
    Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.
    Dadheech S; Madhulatha D; Jainc S; Joseph J; Jyothy A; Munshi A
    Indian J Med Res; 2016 Apr; 143(4):449-54. PubMed ID: 27377501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.